Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Michigan Biomedical Venture Fund
AddedFeb 16, 2024
UpdatedJun 28, 2026
Michigan Biomedical Venture Fund

Michigan Biomedical Venture Fund

Operating

Michigan Biomedical Venture Fund seeds U-M biomedical startups in therapeutics, software, and diagnostics.

Location
Ann Arbor, MI, US
Founded
1869
Firm
Compare
Portfolio
Employees
Website

Michigan Biomedical Venture Fund focuses on seeding early-stage biomedical startups affiliated with the University of Michigan. The fund invests in therapeutics, software, diagnostics, and health information technology companies, with a particular emphasis on ventures utilizing U-M intellectual property or licenses. Typical investments are made at the seed stage.

The fund operates as part of Fast Forward Medical Innovation, offering resources, support, and mentorship to biomedical researchers. Notable portfolio companies include Arcascope, Courage Therapeutics, and FlexDex. In addition to funding, the program provides commercialization education, idea consultations, and business development support to nurture entrepreneurship and groundbreaking research in the biomedical field.

Michigan Biomedical Venture Fund - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments3
Current Portfolio Count3
Total Portfolio Exits0

Top Investment Stages

Seed2 (66.7%)
Series Unknown1 (33.3%)

Stage Mix

Seed 67%Series Unknown 33%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Arcascope logo

Arcascope

FlexDex logo

FlexDex

Courage Therapeutics logo

Courage Therapeutics

Similar Investment Firms

Michigan Angel Fund logo

Michigan Angel Fund

miangelfund.com

Invest Michigan logo

Invest Michigan

investmichigan.org

Michigan Innovate Capital Fund logo

Michigan Innovate Capital Fund

Michigan Emerging Technology Fund logo

Michigan Emerging Technology Fund

mietf.org

Accelerate Blue Fund logo

Accelerate Blue Fund

InvestMichigan logo

InvestMichigan

Michigan Capital Network logo

Michigan Capital Network

MI Ventures logo

MI Ventures

Michigan Accelerator Fund I logo

Michigan Accelerator Fund I

First Step Fund logo

First Step Fund

idventures.com

Social Venture Fund logo

Social Venture Fund

Wolverine Venture Fund logo

Wolverine Venture Fund

zli.bus.umich.edu

Michigan Strategic Fund logo

Michigan Strategic Fund

michigan.org

Quantum Medical Concepts logo

Quantum Medical Concepts

Accelerate Michigan Innovation Competition logo

Accelerate Michigan Innovation Competition

Michigan Biomedical Venture Fund - Classification

NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 12 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 610000Educational Services
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 541000Professional, Scientific, and Technical Services
  • 611000Educational Services
  • 523910Miscellaneous Intermediation
SIC
  • 6000Depository Institutions
  • 7300Business Services
  • 8200Educational Services
  • 6720Investment Offices
  • 8290Schools And Educational Services, Not Elsewhere Classified
  • 6722Management Investment Offices, Open-end